Fogliazza, F.; Berzieri, M.; Carbone, G.; Ciriaco, D.; Esposito, S.
Chronic Hydroxyurea Therapy in Children with Sickle Cell Anemia: Mechanisms of Action, Systemic Effects, and Long-Term Safety. J. Clin. Med. 2025, 14, 8599.
https://doi.org/10.3390/jcm14238599
AMA Style
Fogliazza F, Berzieri M, Carbone G, Ciriaco D, Esposito S.
Chronic Hydroxyurea Therapy in Children with Sickle Cell Anemia: Mechanisms of Action, Systemic Effects, and Long-Term Safety. Journal of Clinical Medicine. 2025; 14(23):8599.
https://doi.org/10.3390/jcm14238599
Chicago/Turabian Style
Fogliazza, Federica, Martina Berzieri, Giulia Carbone, Davide Ciriaco, and Susanna Esposito.
2025. "Chronic Hydroxyurea Therapy in Children with Sickle Cell Anemia: Mechanisms of Action, Systemic Effects, and Long-Term Safety" Journal of Clinical Medicine 14, no. 23: 8599.
https://doi.org/10.3390/jcm14238599
APA Style
Fogliazza, F., Berzieri, M., Carbone, G., Ciriaco, D., & Esposito, S.
(2025). Chronic Hydroxyurea Therapy in Children with Sickle Cell Anemia: Mechanisms of Action, Systemic Effects, and Long-Term Safety. Journal of Clinical Medicine, 14(23), 8599.
https://doi.org/10.3390/jcm14238599